EF
FOLD

Empowered Funds’s Amicus Therapeutics FOLD Stock Holding History

Empowered Funds’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246K Sell
16,986
-95,721
-85% -$1.37M ﹤0.01% 1923
2025
Q4 		$1.6M Buy
+112,707
New +$1.11M 0.03% 549
2017
Q4 		– Sell
-52,713
Closed -$795K – 108
2017
Q3 		$795K Buy
+52,713
New +$697K 0.52% 67

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Empowered Funds's FOLD Position: Q1 2026 in Review

Empowered Funds reduced its Amicus Therapeutics (FOLD) stake by 85% in Q1 2026, selling an estimated $1.37M and leaving 16,986 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1923.

Empowered Funds first reported a position in FOLD in Q3 2017 and has held it in 3 quarters since. The position peaked at $1.6M in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Empowered Funds held 16,986 shares of Amicus Therapeutics worth $246K as of Q1 2026.
  • Empowered Funds sold 95,721 Amicus Therapeutics shares in Q1 2026, an estimated $1.37M.
  • Amicus Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q1 2026, its #1923 holding.
  • Empowered Funds first reported a position in Amicus Therapeutics in Q3 2017 and has held it in 3 quarters since.
  • Empowered Funds's Amicus Therapeutics position peaked at $1.6M in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.